falconer-"blarcamesine provided extremely significant therapeutic improvements."--thank you very much for this detailed-(easy to understand) analysis--"much medical jargon difficult for the average person to comprehend"---I kind of got that from my reading but you nailed it--made it much easier to comprehend--again my thanks to you--many good days ahead for our "wunderdrugs" from Anavex--patients and shareholders to benefit greatly !!!!
What I found most interesting in reading through that paper was in the supplemental materials that you had to down load to see.
As I read the chart S1d the OLE continued to low, med, high dose all the way through the OLE period. It was always an open question for me exactly what dosages the OLE participants were getting.
The information also adds context and understanding to the Figure 3 in the paper. Depending on which group is being plotted, it may contain one or all three dosage levels in the group. Knowing that piece of information puts a different light on each group's responses.
News 
Market Data 
Discover 
AI
